SPDR® S&P Biotech ETF XBI: NYSE Arca All Holdings as of 11/15/2023 Holdings are subject to change. Total healthcare and life sciences M&A was about $71. London. The gross expense ratio is the fund’s total annual operating expenses ratio. 8% of its total assets under management. Get up to date fund holdings for SPDR S&P Biotech ETF from Zacks Investment Research Learn everything about SPDR S&P Biotech ETF (XBI). Index Dividend Yield The weighted average of the underlyings’ indicated annual dividend A high-level overview of SPDR® S&P Biotech ETF (XBI) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Compare ETFs IBB and XBI on performance, AUM, flows, holdings, costs and ESG ratings. 2. Discover historical prices for XBI stock on Yahoo Finance. 71% of total assets under management. XBI. underlying holdings of the fund. Looking at the chart above, XBI's low point in its 52 week range is $61. Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target. 75M), Brown Advisory. IBB’s holdings include many leading biotech companies, with holdings capped at 8% on the five largest constituents and 4% for the remaining holdings. S. So far this year, XBI has lost about -5. IBB vs. 07. Free ratings, analyses, holdings, benchmarks, quotes, and news. Launched on 01/31/2006, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market. View Holdings As of 09/30/2023. Health Care Select Sector SPDR ETF ETF holdings by MarketWatch. Performance and Risk The ETF has lost about -9. The firm has a market cap of $5. 79 as the 52 week high point — that compares with a last trade of $76. Performance and Risk. Nov 20, 2023Top 10 Holdings. Mirati. XBI Description. RGLD. Holdings; Performance; Risk; Performance Overview-12. Viehbacher reported, “In the second quarter, Biogen continued to advance groundbreaking science with the FDA approval of two first-in-class therapies for Alzheimer’s disease and ALS, while also delivering on our. 26% rating in the component of Value. Download as Image. News & World Report, XBI. 84. , Biogen Inc. 96%, and is down about -5. 64 per share, with $174. SPDR® S&P Biotech ETF (XBI) Stock Price, Quote, News & Analysis Save 45%! Get early access to our annual Black Friday Sale » XBI SPDR® S&P Biotech ETF. 78% so far this year and in the past one year (as of 11/20/2023), respectively. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. Discover historical prices for XBI stock on Yahoo Finance. Market Capitalization. In addition to holding 155 positions, its top 10. 97. According to 9 analysts, the average rating for IMGN stock is "Strong Buy. Both FBT and XBI are ETFs. 12 and $91. XBI holdings. Shares of XBI stock opened at $73. comSPDR S&P Biotech ETF is a equity fund issued by SSgA. 17. 0. XLV. View complete XBI exchange traded fund holdings for better informed ETF trading. XBI, whose index recently expanded, also owns only a handful of established biotech companies. 00%) Most Recent Dividend 0. The Composition of the XBI is the Key. 13%: Number of Holdings 77: Price/Book Ratio Price/Book Ratio. At midday the XBI is rebounding indicating there is buying interest near $101. com) ReturnsXBI's top 10 holdings account for about 10. Analysis of these related ETFs and how they are trading may provide insight to this commodity. XBI, MDGL, ARWR, CYTK: Large Inflows Detected at ETF. Toggle navigationNovavax Inc. Looking at the chart above, XBI's low point in its 52 week range is $115. Top 10 Holdings (14. February 15, 2023 — 10:47 am EST. A few losers won't cause XBI to crash. For an investor to take. Holdings AS OF 04/30/2023. Twin City Holdings Ltd from Port Alberni, BC. 66 +2. A collar strategy is a protective option strategy constructed by writing a call and buying a put with the same expiration date while being long the underlying security. Further, the fund owns $6. 35%). The ETF has lost about -30. By Holdings Channel Staff, updated Friday, November 3, 9:50 AM In total we count 672 hedge funds holding XBI as of their latest 13F filing, but among those we've sorted out just the top ten hedge funds holding XBI by largest position size, and presented them here in slideshow format. The sale of ETFs is subject to an activity assessment fee (from $0. As you can see from our holdings in the first chart, we have a sizable exposure to both the ProShares UltraPro QQQ ETF ( NASDAQ: TQQQ) and SPDR S&P Biotech ETF ( NYSEARCA: XBI ). 84% for the trailing three-year period, which makes the fund a high risk choice in the space. 2 %. ValueStrategy: Traditional value investing is an investment strategy where stocks are selected that trade for less than their intrinsic values. 35% vs 0. 50. Below is the comparison between BBC and XBI. 35%). 5% year-to-date and 38. 86 Prior Close 70. 08 per unit, that means that analysts see 59. XBI / SPDR Series Trust - SPDR Biotech ETF short borrow fee rates are shown in the following table. 01% upside for this ETF looking through to the average analyst targets of the underlying holdings. 89%. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one. Rated on Jun 30, 2023 Published on Jun 30. 7% of assets. 53 (+3. This is based on the percent of the fund this stock's assets represent. 10(-0. XBI - SPDR (R) S&P (R) Biotech ETFs top. 7% vs -5. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF. 250-590-1718. m. 23%) Advertisement SPDR S&P Biotech ETF (XBI) NYSEArca - NYSEArca Delayed Price. The portfolio of Cathie Wood updated daily. The ETF has lost about -22. Implied XBI Analyst Target Price: $135. As of the latest information, Bullfrog AI Holdings will launch its initial public offering ( IPO) — or the first time a private enterprise distributes its equity shares to retail (public. Growth of Hypothetical $10,000. LABU. Better trading starts here. XBI: SPDR S&P Biotech ETF - Fund Holdings. Both IBB and XBI have a similar number of assets under management. View Top Holdings and Key Holding Information for Direxion Daily S&P Biotech Bull 3X Shares (LABU). 90 in this past 52. As illustrated more by the next two charts, comparing the top 10 holdings XBI and IBB. 04 per unit, that means that analysts see 73. 38% vs. The table below compares many ETF metrics between IBB and XBI. 35% Expense Ratio 20 40 60 per page Viewing 1-20 of 134 matches 1 2 3 4 5 XBI: SPDR S&P Biotech ETF - Fund Holdings. With XBI trading at a recent price near $122. 12%: Number of Holdings 77: Price/Book Ratio Price/Book Ratio. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. Summary. ETF Channel Staff - Friday, October 20, 6:48 AM. View daily, weekly or monthly formats back to when SPDR S&P Biotech ETF stock was issued. Performance and Risk The ETF has lost about -3. 96%, and is down about -5. Meanwhile, XBI equal weights its holdings. While IBB has many more holdings than XBI (376 vs. 65%. 51. Jun 23, 2022 10:49AM EDT. Holding Companies. 64% for the trailing three-year period, making it a high risk. In contrast, most. Expense ratio and liquidity are average for the group. Lucy Brewster | Nov 10, 2023. XBI, TGTX, VKTX, NVAX: Large Outflows Detected at ETF. Both VHT and XBI are ETFs. The fee is slightly higher for SBIO - . In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"),. 1. 94 per share, with $116. Message board - Online Community of active, educated investors researching and discussing Alaunos Therapeutics, Inc. "The top five holdings in XBI, as of Dec. Implied XBI Analyst Target Price: $135. As of Oct 31 2023. 38%. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. 1% which highlights the scope of the fund and diversification away from company-specific risks. 15 billion assets under management. 06 as the 52 week high point — that compares with a last trade of $102. argenx SE ADR. 31, 2021, are" XBI is an equal weight fund that rebalances each quarter. 76% allocation. com if you have any further questions. The sale of ETFs is subject to an activity assessment fee (from $0. The weighted harmonic average of closing market price divided by. No company usually makes up more than two percent of. 1. XBI has a beta of 0. The sale of ETFs is subject to an activity assessment fee (from $0. Sector Exposure and Top Holdings. . The fund has a beta of 0. The following charts reflect the allocation of WCLD's underlying. Both ARKG and XBI are ETFs. ETF Constituents for S&P Biotech SPDR (XBI) provide detail on the individual stock holdings that make up the ETF. S&P Select Industry Indices are designed to measure the performance of narrow GICS® sub-industries. And, again, it is in the top 15 holdings by weighting of the biotechnology ETF,. XBI, the SPDR S&P Biotech ETF, tracks the performance of the S&P Biotechnology Select Industry Index, offering exposure to the biotechnology sector. XBI. The Global X Genomics & Biotechnology ETF (GNOM) seeks to invest in companies that potentially stand to benefit from further advances in the field of genomic science, such as companies involved in gene editing, genomic sequencing, genetic medicine/therapy, computational genomics, and biotechnology. Company specialized in: Holding Companies. XBI ETF’s holdings offer significant diversification. SPDR S&P Biotech ETF (XBI) NYSEArca - Nasdaq Real Time Price. 60 as the 52 week high point — that compares with a last trade of $69. Holdings. 08%. There is no overlap of the top 10 holdings between SBIO and XBI. Fidelity does not endorse or adopt their content. It can be found in the fund’s most recent prospectus. 85. total market composite index. 73. XBI's top 10 holdings account for about 11. Looking at the chart above, XBI's low point in its 52 week range is $100. The next columns indicate the amount of XBI stock held by each of the funds holding XBI, followed by the XBI position size held by the fund, and lastly the date of the quarterly filing period the data represents. While this ETF allocates. All 142 XBI Holdings. US. The weighted harmonic average of closing market price divided by. 13 and $94. The weighted harmonic average of closing market price divided by. 2 %. ARGX. 37% in the last one. ARGX. 44 per share, with $92. ARKG is an actively managed Exchange Traded Fund (ETF) that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy, and consumer. 01 %IBB: iShares Biotechnology ETF: 0. The. Looking at the chart above, XBI's low point in its 52 week range is $72. com. All 142 XBI Holdings. XBI, HZNP, BIIB, VCYT: ETF Outflow Alert. XBI, the SPDR S&P Biotech ETF, tracks the performance of the S&P Biotechnology Select Industry Index, offering exposure to the biotechnology sector. 37% in the last one. Below is the comparison between VHT and XBI. Netherlands. 20. Overview. 74. The fund employs an equal-weighted methodology, providing a balanced allocation across small, mid, and large-cap biotech companies. *Close price adjusted for splits. The main reason for this is the additional risk mitigation an ETF provides given its myriad holdings within a sector. 1 Y 3 Y $ % Advanced Charting Compare Compare to Benchmark: DJIA S&P 500 GLOBAL DOW NASDAQ Compare to Open 70. ( AMGN) = 9. Looking at the chart above, XBI's low point in its 52 week range is $68. XBI focuses on health care investments and follows the S&P Biotech Index. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. For XBI holdings in the human health space, I think you also have to account for regulatory and policy risk tied to reimbursement rates for expensive drugs. Single Cell Genomics Workflow Automation Cell Analytics Lab Equipment Spatial Genomics Lab Equipment. Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target. . 12% in the last one year (as of 03/16/2023). 80% of total assets under management. Actual Assets Under Management (AUM) is this value plus cash (which is not disclosed). The Global X Genomics & Biotechnology ETF (GNOM) seeks to invest in companies that potentially stand to benefit from further advances in the field of genomic science, such as companies involved in gene editing, genomic sequencing, genetic medicine/therapy, computational genomics, and biotechnology. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. It can be found in the fund’s most recent prospectus. Lenders are funds or individuals that own the security that have indicated to. The adjacent table shows a Realtime Rating for several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. The company’s fifty day. 78% of XBI's total assets under management. $0. Looking at the chart above, XBI's low point in its 52 week range is $62. Looking at the chart above, XBI's low point in its 52 week range is $62. 97. 95. 60 as the 52 week high point — that compares with a last trade of $77. It is gross of any fee waivers or expense reimbursements. ARKG vs XBI Fund Comparison . The big biotech. Again, top 10 holdings. XBI is an equal-weighted ETF that follows the S&P Biotechnology Select Industry Index. 94 per share, with $121. The top 10 holdings account for about 11. Holdings. As I understand it, this attribute was added to the methodology to protect against having too. 0. There is no guarantee the fund will achieve its stated investment objective. 94 per share, with $121. The S&P Biotechnology Select Industry Index comprises stocks in the S&P Total Market Index that are classified in the GICS Biotechnology sub-industry. 5% on the day. 73. View Top Holdings and Key Holding Information for iShares Biotechnology ETF (IBB). 91 Billion . ARKG is an actively managed Exchange Traded Fund (ETF) that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy, and consumer. This index comprises companies in the biotech industry that are a part of the S&P Total Market Index. 88%. The biopharma industry has seen a recent upswing in mergers and acquisitions (M&A). Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. Cash and Equivalents. A comparison between ARKG and XBI based on their expense ratio, growth, holdings and how well they match their benchmark performance. The XBI holdings are quite variable probably helped by algos. 0. S. Many holdings in XBI are cash positive, and the fund itself is cash positive and earning positive too. 43. The fund tracks the performance of a modified market-cap-weighted index of US biotechnology companies listed on US exchanges. by Morningstar Manager Research. 35%. Its holdings reflect the movement of like 750b worth of companies. 03 per $1,000 of principal). 9. 78% of XBI's total assets under management. 94 per share, with $121. Free ratings, analyses, holdings, benchmarks, quotes, and news. XBI is a modified equal weighted ETF with about 157 holdings, though that number may change due to issues such as being acquired, among others. 88 ; Annual Dividend & Yield 0. 61%) At close: 04:00PM ESTSeeks to provide exposure to the Biotechnology segment of the S&P TMI, which comprises the following sub-industries: Biotechnology. iShares Biotechnology ETF ETF holdings by MarketWatch. 51. Morningstar Medalist Rating. 9%: Israel: 3. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. 78% so far this year and in the past one year (as of 11/20/2023), respectively. 01% vs 0. Themes & Subsectors ETFs. 48%: Number of Holdings 78: Price/Book Ratio Price/Book Ratio. VHT has a lower expense ratio than XBI (0. 15 billion assets under management. 47 and a beta of 0. 79 in February 2021 and has fallen over (50%) to $76. View complete XLP exchange traded fund holdings for better informed ETF trading. Price Chart. 66 +2. In the institutional-holders-of-XBI table below, the initial column indicates the name of each top institutional holder of XBI, with a link to that fund's top holdings. Complete SPDR S&P Biotech ETF funds overview by Barron's. 10 as of November 2, 2022. Launched on 01/31/2006, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). Looking at the chart above, XBI's low point in its 52 week range is $62. 09% of its total assets under management. 61%) At close: 04:00PM EST Seeks to provide exposure to the Biotechnology segment of the S&P TMI, which comprises the following sub-industries: Biotechnology. 35% for XBI, but SBIO yields 2. Learn everything about ROBO Global Healthcare Technology and Innovation ETF (HTEC). XBI’s Holdings. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. 66% so far this year and in the past. LABD. View complete XBI exchange traded fund holdings for better informed ETF trading. 97. Top Holdings . It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. Looking at the chart above, XBI's low point in its 52 week range is $72. 96%, and is down about -5. View the top holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI). The vast majority of XBI holdings have less. View daily, weekly or monthly format back to when SPDR S&P Biotech ETF stock was issued. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at , one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where. XBI focuses on health care investments and follows the S&P Biotech Index. Track SPDR Biotech ETF (XBI) Stock Price, Quote, latest community messages, chart, news and other stock related information. 01%). 86% upside for this ETF looking through to the average analyst targets of the underlying holdings. Meanwhile, XBI equal weights its holdings. 51 on Tuesday. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. Based on its analysis of these factors, SSGA Funds Management, Inc. 71%: Number of Holdings 64: Price/Book Ratio Price/Book Ratio. XLY News. 9. The Nasdaq Biotechnology Index is a modified capitalization weighted index that includes securities of The Nasdaq Stock Market listed companies that are classified as either biotechnology or pharmaceutical. 5. XBI holdings. 98 and standard deviation of 37. Search or filter ETFs by fund name, ticker, ISIN, or CUSIP, and browse for SPDR ETFs that align with your investment objectives. 5% year-to-date and 38. 08%. 36% of total assets under management. Find exchange traded funds (ETFs) whose sector aligns with the same commodity grouping as the symbol you are viewing. The stock holdings of the XBI tends to be re. 264,458,476. So far this year, XBI has lost about -5. It is gross of any fee waivers or expense reimbursements. 06 as the 52 week high point — that compares with a last trade of $112. Below is the comparison between IBB and XBI. 51 on Tuesday. XBI provides a unique investment focus, as its holdings are largely small and mid-cap biotech firms rather than larger pharmaceutical companies such as Pfizer and Johnson & Johnson . As can be seen, XBI holds some of the most innovative small-cap biotech companies at equal weight (almost). 94 per share, with $107. $6. As of 9/30/23. 18. The top 10 concentration is much higher than XBI at 38% given it only has 30 holdings compared to XBI's 140+ holdings. 1% over the past year to close the last trading session at $81. Seeks to track a modified. GrowthStrategy: Traditional growth investing is an investment. 7 days ago - Exploring Economic Indicators: Household Debt, Consumer Sentiment, and Trade - ETF Trends 14 days ago - What's Happening in the Labor Market? - ETF Trends ; 21 days ago - GDP Surges as Sentiment Slides: A Week of Economic Insights - ETF Trends 25 days ago - Consumer Discretionary vs. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. SPDR S&P Biotech ETF ( NYSEARCA: XBI) is likely in the early to mid stages of a period of underperformance, both versus its larger-cap peers and the broad US stock market. Sign Up Log In Dashboard LogoutLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. News & World Report, XBI enjoys volume of 20. 15 during this last 52-week period. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. We have highlighted five ETFs from different. Find Direxion Daily S&P Biotech Bull 3X Shares ETF (LABU) top 10 holdings and sector breakdown by %. 2. Visitors trend 2W 10W 9M. ETFs Holding XBI. Direxion Daily FTSE China Bull 3X Shares ETF holdings by MarketWatch. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one. •. Performance and Risk The ETF has lost about -29. 47%. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. VHT has a higher 5-year return than XBI (7. XBI Portfolio - Learn more about the SPDR® S&P Biotech ETF investment portfolio including asset allocation, stock style, stock holdings and more. 11. The 10 largest holdings have a combined 17. View the XBI funds market news. Its price to cash flow multiples is about 13. 94 as the 52 week high point — that compares with a last trade of $116. Holdings. The following charts reflect the geographic spread of WCLD's underlying holdings. Its fund flows were negative $259. Further, the fund owns $6.